Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
Epilepsy Res. 2014 Aug;108(6):1095-105. doi: 10.1016/j.eplepsyres.2014.04.011. Epub 2014 May 13.
[(18)F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is a semi-invasive, interictal method of localization of hypometabolic epileptic foci. FDG-PET can be useful in the clinical work-up prior to epilepsy surgery, especially in equivocal cases. We investigated whether we could increase the yield of presurgical FDG-PET in patients with difficult epilepsy requiring chronic subdural electrocorticography (ECoG).
We retrospectively studied patients with refractory focal epilepsy in whom there was uncertainty about the focus localization and who underwent FDG-PET and ECoG. Two experts (epileptologist and nuclear medicine radiologist) together systematically re-assessed the scans visually (PETRE), blinded to their initial reports. Scans were also re-analyzed by comparing them to a normal control dataset with Statistical Parametric Mapping (SPM), using a liberal (PETSPM1), and strict (PETSPM2) statistical threshold. Regions with hypometabolism and regions containing the seizure onset zone (SOZ) in ECoG were marked as positive anatomical regions (PARs). We compared the concordance of these PARs for the different PET re-assessments. We calculated the sensitivity, specificity and accuracy of the PET results for the SOZ. The added value of the re-assessments was evaluated with emphasis on scans initially reported as negative.
41 Patients (63% extra-temporal) were included. PETRE identified the SOZ best, with a sensitivity of 62% and specificity of 93%. PETSPM1 had a sensitivity of 62% and specificity 69%, for PETSPM2 this was 35% and 85% respectively. The overlap between PETRE vs. PETSPM1 and vs. PETSPM2 was 71% and 37%. Visual re-assessment and PETSPM1 identified the SOZ in four out of five scans that were initially reported as negative.
Pre-surgical re-assessment of PET scans is worthwhile in epilepsy patients who undergo ECoG, especially when results were reported as negative before. Visual re-assessment itself has a higher combined specificity, sensitivity and accuracy than SPM analysis alone. SPM analysis could be used as a guide for visual (re-)assessment, because of its high sensitivity.
[(18)F]氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)是一种半侵袭性的、发作间期的方法,用于定位代谢低下的癫痫灶。FDG-PET 在癫痫手术前的临床评估中可能有用,特别是在情况不明的情况下。我们研究了在需要慢性硬膜下脑电描记术(ECoG)的难治性癫痫患者中,是否可以增加术前 FDG-PET 的检出率。
我们回顾性研究了难治性局灶性癫痫患者,这些患者的焦点定位不确定,并进行了 FDG-PET 和 ECoG 检查。两位专家(癫痫学家和核医学放射科医生)一起系统地对扫描进行了视觉评估(PETRE),对其初始报告进行了盲法评估。还通过与使用宽松(PETSPM1)和严格(PETSPM2)统计阈值的正常对照数据集进行比较,对扫描进行了重新分析。代谢低下的区域和 ECoG 中包含发作起始区(SOZ)的区域被标记为阳性解剖区域(PAR)。我们比较了不同 PET 重新评估的这些 PAR 的一致性。我们计算了 SOZ 的 PET 结果的灵敏度、特异性和准确性。强调对最初报告为阴性的扫描进行重新评估的附加值。
41 名患者(63%为颞外)被纳入研究。PETRE 对 SOZ 的识别最佳,灵敏度为 62%,特异性为 93%。PETSPM1 的灵敏度为 62%,特异性为 69%,PETSPM2 的灵敏度为 35%,特异性为 85%。PETRE 与 PETSPM1 之间以及与 PETSPM2 之间的重叠率分别为 71%和 37%。视觉重新评估和 PETSPM1 在最初报告为阴性的五分之四的扫描中识别出了 SOZ。
在接受 ECoG 的癫痫患者中,术前重新评估 PET 扫描是值得的,尤其是当最初报告结果为阴性时。与单独使用 SPM 分析相比,视觉重新评估本身具有更高的特异性、敏感性和准确性。由于其高灵敏度,SPM 分析可作为视觉(重新)评估的指南。